Document and Entity Information
Document and Entity Information | Apr. 05, 2022 |
Cover [Abstract] | |
Amendment Flag | false |
Entity Central Index Key | 0001708493 |
Document Type | 8-K |
Document Period End Date | Apr. 5, 2022 |
Entity Registrant Name | Harpoon Therapeutics, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-38800 |
Entity Tax Identification Number | 47-3458693 |
Entity Address, Address Line One | 131 Oyster Point Blvd |
Entity Address, Address Line Two | Suite 300 |
Entity Address, City or Town | South San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | (650) |
Local Phone Number | 443-7400 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common stock, par value $0.0001 per share |
Trading Symbol | HARP |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |